ZAVENTEM, Belgium — In 1992, the Inovoject® device launched by Embrex® was a major advance in poultry health, ending the devastating impact of Marek’s disease on poultry flocks in the United States. Since then, the groundbreaking technology has continued to develop and expand to cover other common poultry diseases complementing the continuum of care for poultry in preventing diseases thanks to automated vaccination, the company noted.
“Embrex BioDevices® are now used to inject more than 20 billion eggs every year in 30 countries around the world. And we are incredibly proud of the positive impact it has had since it. . .